FDA calls for investigation into its own approval of Biogen’s Alzheimer’s drug

The acting commissioner of the Food and Drug Administration has called for a government investigation into her own agency’s approval of Biogen’s new Alzheimer’s disease drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.